1976, ISBN 9780395207154, x, 356 p., [6] leaves of plates
Book
1795, A new edition, in three volumes., 3 v.
Book
1973, Scientific series, no. 36, v, 22 p. illus.
Book
1970, Technical bulletin (Canada. Inland Waters Branch), Volume 28., vii, 61
The geometry of the small boat basin at the CCIW causes multiple reflections of any wave agitation which enters. Consequently, there is a limit to the amount...
breakwaters | models | wave action | boats | wave attenuation
breakwaters | models | wave action | boats | wave attenuation
Book
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 1, pp. 11 - 20
In patients with acute ischemic stroke due to a proximal intracranial arterial occlusion, intraarterial treatment (with retrievable stents in 82% of patients)...
MEDICINE, GENERAL & INTERNAL | CEREBRAL INFARCT | THERAPY | SCORE | ENDOVASCULAR TREATMENT | RECANALIZATION | OCCLUSIONS | Single-Blind Method | Acute Disease | Urokinase-Type Plasminogen Activator - therapeutic use | Catheterization | Brain Ischemia - therapy | Humans | Middle Aged | Logistic Models | Male | Combined Modality Therapy | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Brain Ischemia - drug therapy | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Odds Ratio | Mechanical Thrombolysis | Stroke - therapy | Stroke (Disease) | Care and treatment | Usage | Arterial catheterization | Cardiac patients | Health aspects | Risk factors | Stroke | Intravenous administration | Medical imaging | Ischemia | Cerebral blood flow | Medical treatment | Implants | Clinical trials | Hemorrhage | Patients | Veins & arteries
MEDICINE, GENERAL & INTERNAL | CEREBRAL INFARCT | THERAPY | SCORE | ENDOVASCULAR TREATMENT | RECANALIZATION | OCCLUSIONS | Single-Blind Method | Acute Disease | Urokinase-Type Plasminogen Activator - therapeutic use | Catheterization | Brain Ischemia - therapy | Humans | Middle Aged | Logistic Models | Male | Combined Modality Therapy | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Brain Ischemia - drug therapy | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Odds Ratio | Mechanical Thrombolysis | Stroke - therapy | Stroke (Disease) | Care and treatment | Usage | Arterial catheterization | Cardiac patients | Health aspects | Risk factors | Stroke | Intravenous administration | Medical imaging | Ischemia | Cerebral blood flow | Medical treatment | Implants | Clinical trials | Hemorrhage | Patients | Veins & arteries
Journal Article
EUROPEAN SPINE JOURNAL, ISSN 0940-6719, 09/2017, Volume 26, Issue 9, pp. 2272 - 2273
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00586-017-5059-x
ORTHOPEDICS | CLINICAL NEUROLOGY | Spine
ORTHOPEDICS | CLINICAL NEUROLOGY | Spine
Journal Article
1970, Technical bulletin, Volume no. 28., 61
Book
IEEE Transactions on Magnetics, ISSN 0018-9464, 05/2013, Volume 49, Issue 5, pp. 1637 - 1640
A method for parameter identification of J-A hysteresis model is presented. This method is based on combination of pattern search and nonlinear least square...
Jiles-Atherton model | Computational modeling | Magnetization | Core loss | Predictive models | least square method | Magnetic hysteresis | Numerical models | parameter optimization | Mathematical model | Optimization | hysteresis | magnetization | PHYSICS, APPLIED | IDENTIFICATION | ENGINEERING, ELECTRICAL & ELECTRONIC | Technology application | Usage | Mathematical optimization | Analysis | Hysteresis | Least squares | Pattern search | Least squares method | Nonlinearity | Mathematical models | Inverse | Parameter identification
Jiles-Atherton model | Computational modeling | Magnetization | Core loss | Predictive models | least square method | Magnetic hysteresis | Numerical models | parameter optimization | Mathematical model | Optimization | hysteresis | magnetization | PHYSICS, APPLIED | IDENTIFICATION | ENGINEERING, ELECTRICAL & ELECTRONIC | Technology application | Usage | Mathematical optimization | Analysis | Hysteresis | Least squares | Pattern search | Least squares method | Nonlinearity | Mathematical models | Inverse | Parameter identification
Journal Article
Science, ISSN 0036-8075, 2018, Volume 360, Issue 6395, pp. 1313 - 1313
Disorders of the brain can exhibit considerable epidemiological comorbidity and often share symptoms, provoking debate about their etiologic overlap. We...
ANOREXIA-NERVOSA | POPULATION-BASED TWIN | DEFICIT HYPERACTIVITY DISORDER | LONG-TERM SURVIVAL | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | GENETIC CORRELATIONS | BODY-MASS INDEX | MAJOR DEPRESSIVE DISORDER | BIPOLAR DISORDER | GENOME-WIDE ASSOCIATION | Genetic Variation | Mental Disorders - genetics | Genome-Wide Association Study | Phenotype | Brain Diseases - classification | Quantitative Trait, Heritable | Brain Diseases - diagnosis | Humans | Mental Disorders - classification | Risk Factors | Brain Diseases - genetics | Mental Disorders - diagnosis | Anorexia | Disorders | Cognitive ability | Bipolar disorder | Posttraumatic stress disorder | Mental depression | Epidemiology | Risk factors | Consortia | Proteins | Ischemia | Etiology | Classification | Gilles de la Tourette syndrome | Alzheimer's disease | Neurological disorders | Neurodegenerative diseases | Comorbidity | Behavior disorders | Anorexia nervosa | Risk analysis | Patients | Neurological diseases | Correlation analysis | Heritability | Attention deficit disorder | Headache | Mental disorders | Medical services | Schizophrenia | Risk sharing | Genomes | Heterogeneity | Biological effects | Risk assessment | Stroke | Phenotypes | Migraine | Attention deficit hyperactivity disorder | Eating disorders | Personality | Genetic diversity | Statistics | Activity patterns | Crohn's Disease | Population (statistical) | Scaffolding | Diagnostic systems | Alzheimers disease | Life Sciences | Human health and pathology | Mental Disorders | Neurons and Cognition | Brain Diseases | Genetics
ANOREXIA-NERVOSA | POPULATION-BASED TWIN | DEFICIT HYPERACTIVITY DISORDER | LONG-TERM SURVIVAL | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | GENETIC CORRELATIONS | BODY-MASS INDEX | MAJOR DEPRESSIVE DISORDER | BIPOLAR DISORDER | GENOME-WIDE ASSOCIATION | Genetic Variation | Mental Disorders - genetics | Genome-Wide Association Study | Phenotype | Brain Diseases - classification | Quantitative Trait, Heritable | Brain Diseases - diagnosis | Humans | Mental Disorders - classification | Risk Factors | Brain Diseases - genetics | Mental Disorders - diagnosis | Anorexia | Disorders | Cognitive ability | Bipolar disorder | Posttraumatic stress disorder | Mental depression | Epidemiology | Risk factors | Consortia | Proteins | Ischemia | Etiology | Classification | Gilles de la Tourette syndrome | Alzheimer's disease | Neurological disorders | Neurodegenerative diseases | Comorbidity | Behavior disorders | Anorexia nervosa | Risk analysis | Patients | Neurological diseases | Correlation analysis | Heritability | Attention deficit disorder | Headache | Mental disorders | Medical services | Schizophrenia | Risk sharing | Genomes | Heterogeneity | Biological effects | Risk assessment | Stroke | Phenotypes | Migraine | Attention deficit hyperactivity disorder | Eating disorders | Personality | Genetic diversity | Statistics | Activity patterns | Crohn's Disease | Population (statistical) | Scaffolding | Diagnostic systems | Alzheimers disease | Life Sciences | Human health and pathology | Mental Disorders | Neurons and Cognition | Brain Diseases | Genetics
Journal Article
Nature, ISSN 0028-0836, 01/2012, Volume 481, Issue 7380, pp. 157 - 163
Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy of unknown genetic basis. We performed whole-genome sequencing of 12...
REARRANGEMENT | RAS | MULTIDISCIPLINARY SCIENCES | ACTIVATING FLT3 MUTATIONS | EXPRESSION | CRLF2 | RUNX1 | ETV6 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Genomics | Humans | Molecular Sequence Data | Janus Kinases - metabolism | Stem Cells - metabolism | Receptors, Interleukin-7 - genetics | T-Lymphocytes - metabolism | Leukemia, Myeloid, Acute - drug therapy | T-Lymphocytes - pathology | Child | Genes, ras - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Genetic Predisposition to Disease - genetics | Janus Kinases - genetics | Leukemia, Myeloid, Acute - pathology | Hematopoiesis - genetics | DNA Copy Number Variations - genetics | Signal Transduction - genetics | Mutation - genetics | Sequence Analysis, DNA | Genome, Human - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Age of Onset | Stem Cells - pathology | Histones - metabolism | Leukemia, Myeloid, Acute - genetics | Translocation, Genetic - genetics | Bone marrow | Genetics | Genomes | Mutation | Gene expression
REARRANGEMENT | RAS | MULTIDISCIPLINARY SCIENCES | ACTIVATING FLT3 MUTATIONS | EXPRESSION | CRLF2 | RUNX1 | ETV6 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Genomics | Humans | Molecular Sequence Data | Janus Kinases - metabolism | Stem Cells - metabolism | Receptors, Interleukin-7 - genetics | T-Lymphocytes - metabolism | Leukemia, Myeloid, Acute - drug therapy | T-Lymphocytes - pathology | Child | Genes, ras - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Genetic Predisposition to Disease - genetics | Janus Kinases - genetics | Leukemia, Myeloid, Acute - pathology | Hematopoiesis - genetics | DNA Copy Number Variations - genetics | Signal Transduction - genetics | Mutation - genetics | Sequence Analysis, DNA | Genome, Human - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Age of Onset | Stem Cells - pathology | Histones - metabolism | Leukemia, Myeloid, Acute - genetics | Translocation, Genetic - genetics | Bone marrow | Genetics | Genomes | Mutation | Gene expression
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 26, pp. 2492 - 2503
Among patients with type 2 diabetes and stage 4 chronic kidney disease, bardoxolone methyl, as compared with placebo, did not reduce the risk of end-stage...
TRIAL | NRF2 | ANALOGS | RENAL EVENTS BEACON | OUTCOMES | IRBESARTAN | NEPHROPATHY | CKD | MEDICINE, GENERAL & INTERNAL | Cardiovascular Diseases - etiology | Glomerular Filtration Rate | Double-Blind Method | Humans | Middle Aged | Oleanolic Acid - analogs & derivatives | Kaplan-Meier Estimate | Diabetic Nephropathies - drug therapy | Male | Weight Loss - drug effects | Renal Insufficiency, Chronic - physiopathology | Renal Insufficiency, Chronic - drug therapy | Kidney Failure, Chronic - prevention & control | NF-E2-Related Factor 2 - metabolism | Treatment Failure | Intention to Treat Analysis | Cardiovascular Diseases - mortality | Female | Oleanolic Acid - adverse effects | Aged | Oleanolic Acid - therapeutic use | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Evaluation | Care and treatment | Dosage and administration | Terpenes | Risk factors | Diabetic nephropathies | Hypertension | Creatinine | End-stage renal disease | Oxidative stress | Kidneys | Diabetes mellitus | Body weight | Clinical trials | Aldosterone | Glomerular filtration rate | Renin | Angiotensin | Blood pressure | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases
TRIAL | NRF2 | ANALOGS | RENAL EVENTS BEACON | OUTCOMES | IRBESARTAN | NEPHROPATHY | CKD | MEDICINE, GENERAL & INTERNAL | Cardiovascular Diseases - etiology | Glomerular Filtration Rate | Double-Blind Method | Humans | Middle Aged | Oleanolic Acid - analogs & derivatives | Kaplan-Meier Estimate | Diabetic Nephropathies - drug therapy | Male | Weight Loss - drug effects | Renal Insufficiency, Chronic - physiopathology | Renal Insufficiency, Chronic - drug therapy | Kidney Failure, Chronic - prevention & control | NF-E2-Related Factor 2 - metabolism | Treatment Failure | Intention to Treat Analysis | Cardiovascular Diseases - mortality | Female | Oleanolic Acid - adverse effects | Aged | Oleanolic Acid - therapeutic use | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Evaluation | Care and treatment | Dosage and administration | Terpenes | Risk factors | Diabetic nephropathies | Hypertension | Creatinine | End-stage renal disease | Oxidative stress | Kidneys | Diabetes mellitus | Body weight | Clinical trials | Aldosterone | Glomerular filtration rate | Renin | Angiotensin | Blood pressure | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article